The interaction between Avelox and bovine serum albumin (BSA) was investigated at different temperatures by fluorescence spectroscopy. Results showed that Avelox could quench the intrinsic fluorescence of BSA strongly, and the quenching mechanism was a static quenching process with Förester spectroscopy energy transfer. The electrostatic force played an important role on the conjugation reaction between BSA and Avelox. The order of magnitude of binding constants (K a ) was 10 4 , and the number of binding site (n) in the binary system was approximately equal to 1. The binding distance (r) was less than 3 nm and the primary binding site for Avelox was located in subdomain IIA of BSA. Synchronous fluorescence spectra clearly revealed that the microenvironment of amino acid residues and the conformation of BSA were changed during the binding reaction. In addition, the effect of some antibiotics on the binding constant of Avelox with BSA was also studied.
Introduction
Most drugs are able to bind to plasma protein when they entrance in blood plasma system of organism, and serum albumin is the most abundant protein in blood plasma and serves as a depot protein and transport protein for numerous endogenous and exogenous compounds [1] . Generally speaking, drugs could bind with serum albumin mostly through the formation of noncovalent complexes reversibly. The drug-protein complex can be regarded as a form of drug in the biology temporary storage, it can effectively avoid drug elimination from metabolism so quickly that it can maintain the total concentration and effective concentrations of blood medicine in plasma. In addition, binding of drugs to plasma proteins controls their free, active concentrations and provides a reservoir for a longer action, the binding of drugs is responsible for the protective role of albumin. Therefore, interaction of a drug with, and competition for, the binding sites on plasma proteins might strongly affect its distribution, elimination, as well as its pharmacodynamics and toxic properties [2] . Competition between two drugs for their binding to plasma protein can strongly affect the drug disposition of both drugs, with possible serious physiological consequences. Binding parameters are indeed fundamental factors in determining the overall pharmacological activity of a drug, and in this context the determination of the binding parameters of drugs to albumin has become essential to understand their pharmacokinetic, pharmacodynamic, and toxicological profile.
Avelox is a new generation of fluoroquinolone antibacterial agents, which is used to treat a wide variety of bacterial infections including pneumonia, sinusitis, and worsening of chronic bronchitis (the structure is shown in Figure 1 ). This medicine gradually played a significant role in clinical cure. At present, the molecular interactions between BSA and many drugs have been investigated successfully in biomedical domain [3] . However, the interaction between Avelox and BSA has not been investigated, especially the effect of the common antibiotics on the binding of drugs to BSA. In this paper, we provided investigations on the interaction of Avelox with BSA by fluorescence spectroscopy under physiological pH 7.40 as well as the effect of the coexistent drugs. This study is expected to provide important insight into the essence, potential toxicity between drugs and protein in real terms, and can also provide a useful clinical reference for future combination therapy. 
Experimental
2.1. Apparatus. All fluorescence spectra were recorded with a Shimadzu RF-540 spectrofluorophotometer and a Hitachi F-4500 spectrofluorophotometer. Absorption was measured with an UV-vis recording spectrophotometer (UV-265 Shimadzu, Japan). All pH measurements were made with a pHS-3C precision acidity meter (Leici, Shanghai). All temperatures were controlled by a CS501 superheated water bath (Nantong Science Instrument Factory).
Materials.
Avelox (no less than 99.9% pure) was obtained from monitor of Chinese veterinary medicine. Bovine serum albumin (BSA, no less than 99% pure) was purchased from Sigma Company. Warfarin (WF), Chlorpheniramine (CP), and digitoxin (DG) were all obtained from Chinese Institute of Drug and Biological Products. Stock solutions of BSA (1.0 × 10 −4 M) and Avelox (2.0 × 10 −3 M) were prepared. And all the stock solutions were further diluted as working solutions prior to use. All the common antibiotics were diluted to 1.0 × 10 −3 M. Tris-HCl buffer solution containing NaCl (0.15 M) was used to keep the pH of the solution at 7.40. NaCl solution was used to maintain the ionic strength of the solution. All other reagents were of analytical grade, and all aqueous solutions were prepared with newly double-distilled water and stored at 277 K.
The fluorescence intensities were corrected for the absorption of excitation light and reabsorption of emitted light to decrease the inner filter using the following relationship [4] :
where F cor and F obs are the corrected and observed fluorescence intensities, respectively. A ex and A em are the absorbance values of Avelox at excitation and emission wavelengths, respectively. The fluorescence intensity used in this paper was corrected. 
Results and Discussion

3.1.
Interaction between Avelox and BSA. Based on Section 2.3.1, we have drawn the fluorescence spectra of BSA as well as different Avelox added into BSA, respectively. When the excitation wavelengths were at 280 nm and 295 nm, the emission peaks for BSA were both located at 343 nm. In this part, we also found that Avelox had fluorescence at 462 nm obviously, but it had weak fluorescence at 343 nm. According to this phenomenon, we scanned the solution on the fluorophotometer with the range 300-450 nm and recorded the fluorescence spectra of BSA-Avelox without Avelox which were shown in Figure 2 . As can be seen from Figure 2 , the fluorescence intensity of BSA decreased regularly with the addition of Avelox, and the maximum emission wavelength had 9 nm red shifts from 343 nm to 352 nm. This result implied that Avelox could quench the intrinsic fluorescence of BSA strongly, and the interaction between Avelox and BSA resulted from the formation of a ground-state complex between this drug and protein. In addition, the UV absorption intensity of Avelox which located at 336 nm and 308 nm decreased with increased concentrations of BSA (as seen in Figure 3 ), it could also reveal that the formation of new complex, in addition suggested that the quenching was a static process. the collisional encounter between the drug and protein, or static quenching, resulting from the formation of a ground-state complex between the drug and protein. Higher temperature would result in faster diffusion and typically the dissociation of weekly bound complexes, leading to larger amount of dynamic quenching and smaller amounts of static quenching, respectively [5] . In order to confirm the quenching mechanism, the fluorescence quenching data are analyzed by the Stern-Volmer equation [6] :
Fluorescence Quenching
where F 0 and F are the fluorescence intensities in the absence and presence of ligand, respectively. (1) to (6),
the increase in temperature for all systems, which indicated that the probable quenching mechanism of the interaction between BSA and Avelox was initiated by complex formation rather than by dynamic collision [7] . In addition, all the values of K q were much greater than the maximum scatter collision quenching constant of various quenchers (2 × 10 10 M −1 s −1 ) [8] . This also suggested that the quenching was a static process [9] .
For static quenching process, the relationship between the fluorescence intensity and the concentration of quencher can be usually described by deriving (3) [10] to obtain the binding constant (K a ) and the number of binging sites (n) in most of paper:
where [D t ] and [B t ] are the total concentrations of Avelox and protein, respectively. On the assumption that n in the bracket is equal to 1, the curve of log(
and fitted linearly, then the value of n can be obtained from the slope of the plot. If the n value obtained is not equal to 1, then it is substituted into the bracket and the curve of log( 
K q is the quenching rate constant; K a is the binding constant; n is the number of binding site.
with the increasing temperature, further suggested that the quenching was a static process [11] , hence it led to the reduced of the stability of binary systems. On the other hand, comparing the data of 280 nm with 295 nm, values of K a and n had less difference at different temperatures, it explained that Avelox would mainly quench the fluorescence of tryptophanyl residues from BSA.
Type of Interaction Force of the Binary Systems.
Generally, the interaction forces between the small drug molecule and biological macromolecule include hydrogen bond, Van der Waals force, electrostatic interactions, and hydrophobic force [12] . Ross and Subramanian [13] have characterized the sign and magnitude of the thermodynamic parameter, enthalpy change (ΔH), free energy (ΔG), and entropy change (ΔS) of reaction, associated with various individual kinds of interaction. The reaction ΔH can be regarded as constant if the temperature changes little. Negative ΔH and positive ΔS indicate that electrostatic interaction plays a major role in the binding reaction. Positive ΔH and ΔS are generally considered as the evidence for typical hydrophobic interactions. In addition, Van der Waals force and hydrogen bonding formation in low-dielectric media are characterized by negative ΔH and ΔS [14] . The thermodynamic parameters can be calculated on the basis of the following equations:
According to the binding constants K a of Avelox to BSA at different temperatures above ( Trp and Tyr residues in serum albumin are excited, whereas the 295 nm wavelength excites only Trp residues. In the subdomains of BSA, IIA subunit (Trp and Tyr) and IIIA (Tyr) are also considered as the main binding sites for smalldrug molecule [15] . Based on the Stern-Volmer equation, comparing the fluorescence quenching of protein excited at 280 nm and 295 nm allows to estimate the participation of Trp and Tyr groups in the complex [16] . As seen in Figure 4 , the quenching curves of BSA excited at 280 nm and 295 nm in the presence of Avelox overlap below the molar ratio Avelox : BSA = 80 : 1. This means that if there are fewer than 80 Avelox molecules for 1 BSA molecules, only Trp residues take part in the interaction of Avelox with BSA, and protein fluorescence was quenched by almost 80% at the molar ratio 80 : 1. The quenching of BSA fluorescence exited at 280 nm above this molar ratio was slightly higher than that excited at 295 nm which means that Tyr residues began to take part in the interaction. According to this conclusion, it could be inferred that Avelox molecules only take interaction with Trp residues of BSA at low concentration, whereas both Trp and Tyr residues at high concentration, this conclusion can also expound why the value of n is slightly more than 1, which has been shown in Table 1 .
BSA has two Trp moieties (Trp-134 and Trp-212) located in subdomains IB and IIA, respectively, and only Trp-212 is located within a hydrophobic binding pocket of the protein which usually bind many small ligands, especially heterocyclic ligands of average size and small aromatic carboxylic acids [17] . In this way, it could confirm that the primary binding site for Avelox was located in subdomain IIA of BSA.
Site marker fluorescent probes are useful for rapid identification of drug binding sites [18, 19] . In order to estimate the drug binding sites on BSA, Sudlow et al. have proposed the percentage of probe replacement method using the following equation [20] :
The concentrations of BSA and Avelox were kept constant (1 × 10 −6 M), while that different concentrations of various probe drugs each were added into it. In the study of the substitution reaction, F 1 and F 2 are the fluorescence intensities in the absence and presence probe drug. In this paper, we have considered WF, CP, and DG as probe durgs which bind specifically to sites I, II, and III, respectively. The processed results were shown in Figure 5 by (6) .
As seen in Figure 5 , relative fluorescence intensities decreased obviously with increasing concentration of WF, whereas it almost kept constant with the adding of CP and DG. It indicated that Avelox was pronouncedly displaced by WF rather than CP or DG, hence it could be inferred that the binding site for Avelox was site I which located in subdomain IIA of BSA.
At room temperature (293 K), control the concentrations of BSA and various probe drugs each at 1 × 10 −6 M. According to the method described in Section 2.3.1, successively adding different concentrations of Avelox. The experimental 
Hill's Coefficient of BSA-Avelox
System. In biochemistry, the binding of a ligand molecule at one site of a macromolecule often influences the affinity for other ligand molecules at additional sites. This is known as cooperative binding. It is classified into positive cooperativity, negative cooperativity, and noncooperativity according to the promotion or inhibition to the affinity for other ligand molecules. Hill's coefficient provides a way to quantify this effect and is calculated graphically on the basis of the following equation [21] :
where Y is the fractional binding saturation; K is the binding constant and n H is the Hill's coefficient. Hill's coefficient is greater than one, which exhibits positive cooperativity. Conversely, Hill's coefficient is less than one, which exhibits negative cooperativity. A coefficient of 1 indicates noncooperative reaction. For fluorescence measurement:
where
Hill's coefficients were presented in Table 2 . The values of n H were slightly less than 1 in the systems, both at excitation wavelengths 280 nm and 295 nm at different temperatures, which indicated negative cooperativeness in the interaction of Avelox with BSA, but they were weak. In addition, the values of n H were inversely correlated with increasing temperature illustrating the existence of negative cooperativity between Avelox and BSA, that was, the ability of drug bounding to BSA has decreased with the previous ligand (Avelox) bounding to BSA gradually. Furthermore, this negative cooperativity became more powerful with increasing temperature, reducing the amount of Avelox that could be bound to BSA. It was also one of the reasons which led to the reduced K a with increasing temperature.
Binding Distances between Avelox and BSA.
Fluorescence energy transfer is categorized as radiation energy transfer and nonradiation energy transfer. The fluorescence spectrum will deform if radiation energy transfer occurred. The fluorescence spectrum in Figure 2 has no deformation, thus the energy transfer of BSA and Avelox should be nonradiation energy transfer.
According to Förster's nonradiative energy transfer theory, energy efficiency E, critical energy-transfer distance R 0 (E = 50%), the energy donor, the energy acceptor distance r, the overlap integral, between the fluorescence emission spectrum of the donor, and the absorption spectrum of the acceptor J can be calculated by the formulas [22] :
where K 2 is the orientation factor, Φ is the fluorescence quantum yield of the donor, N is a refractive index of the medium, F(λ) is the fluorescence intensity of the fluorescence donor at wavelength λ, and ε(λ) is the molar absorption coefficient of the acceptor at this wavelength.
The overlap of UV-vis absorption spectra of Avelox and the fluorescence emission spectra of BSA (λ ex = 280 nm) were shown in Figure 6 . Under these experimental conditions, it has been reported that K 2 = 2/3, N = 1.336, and Φ = 0.118 [23] . Thus J, E, R 0 , and r were calculated and shown in Table 3 . The donor-to-acceptor distance r < 7 nm indicated that the energy transfer from BSA to Avelox R 0 is the critical distance when E is 50%; r is the distance between acceptor and donor; J is the overlap integral between the fluorescence emission spectrum of donor and the absorption spectrum of the acceptor.
occured with high possibility [24] . Furthermore, the value of r was greater than R 0 in this study which suggested that Avelox could strongly quench the intrinsic fluorescence of BSA by a static quenching mechanism [25] . Moreover, the distance r increased, and the energy efficiency E decreased with increasing temperature (Table 3) , which resulted in the reduced stability of the binary systems and the values of K a .
Conformation Investigation of BSA.
Synchronous fluorescence spectra are used to investigate the protein conformational change, as it has been shown to give narrow and simple spectra. For the synchronous fluorescence spectra of protein, when the Δλ value between the excitation and emission wavelengths is stabilized at either 15 or 60 nm, the synchronous fluorescence gives characteristic information for Tyr residues or Trp residues [26] . Because of the red shifts of maximum emission wavelengths of both Tyr and Trp with the less hydrophobic environment, blue shifts of maximun emission wavelengths with the more hydrophobic environment ocurr. These red or blue shifts indicated that the conformation of BSA has been changed [27] . In order to further study the effect on the conformation of BSA, the synchronous fluorescence spectra were measured when the Δλ = 15 nm and Δλ = 60 nm as shown in Figure 7 . It can be seen from Figure 7 that the fluorescence intensities of Tyr and Trp residues decreased regularly with increasing concentration of Avelox. At the same time, the maximum emission wavelength had 4 nm blue shifts at the investigated concentrations range when Δλ = 60 nm, while the maximum emission wavelength had 7 nm red shifts when Δλ = 15 nm. This revealed that the aminoacids microenvironment changed due to the reaction of Avelox and BSA, making the hydrophobicity of Trp residues strengthened, whereas, the hydrophobic environment of Tyr residues more polar. High concentration of drugs makes protein molecules extend, thus reducing energy transfer between aminoacids, reducing the fluorescence intensity [28] . presence of antibiotice. It supposed that there was no effect on the binding of BSA-Avelox system when the value of (F 2 − F 1 )/F 1 was less than ±5% by (6) , that was, this antibiotice could coexist with Avelox. The results showed that it allowed 500 times of gentamicin, thiamphenicol, 300 times of sulfamethoxazole, erythromycin and streptomycin, 100 times of ampicillin, neomycin and kanamycin, 20 times of penicillin G sodium salt and acetyl spiramycin, and 10 times of cefotaxime sodium, cefoperazone sodium, ceftriaxone, and chloramphenicol to coexist with Avelox, but a bit of ciprofloxacin, and norfloxacin could disturb the stability of BSA-Avelox system, making the fluorescence intensity change a lot. It might result that Avelox and ciprofloxacin, norfloxacin all belong to a class of drugs called quinolone antibiotics, having much similar structures, hence, there was certain competition among them for the protein. The competition would lead to binding constant K a change spontaneously. It could be inferred that there were possible effects on the stayedtime from the blood, as well as plasma concentration and effective concentration, having effects on the efficacy of drugs when the antibiotics such as ciprofloxacin and norfloxacin coexist with Avelox on the binding reaction of BSA. However, aminoglycosides, macrolides, sulfonamides, and penicillin antibiotics have no effects on the binary system, that is, those antibiotics will not affect the transportation of Avelox though BSA when they coexist with Avelox and also have no effects on the efficacy of Avelox.
Effect of the Coexistent
Conclusions
In this paper, the interaction of Avelox with BSA was studied at different temperatures by fluorescence spectroscopic methods. The experimental results indicated that Avelox molecular had embedded into the hydrophobic cavity through electrostatic force and was mainly bound to Trp-212 in BSA. The donor-to-acceptor distance r was less than 7 nm, indicating nonradiation energy transfer. The negative cooperativity existed in BSA-Avelox system for subsequent ligand. From the synchronous fluorescence spectra, it could be shown that the quaternary conformational change of BSA was induced by the interaction of Avelox with the Trp microregion of BSA molecules. The method-like percentage of probe replacement clearly revealed the existence of effects of common antibiotics on the binding of BSA-Avelox system. The study will extend the use of fluorescence spectroscopy; meanwhile, it provides important insights into the future clinical medicine.
